Itaru Hashimoto
Overview
Explore the profile of Itaru Hashimoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
108
Citations
267
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Esashi R, Aoyama T, Yamamoto S, Maezawa Y, Hashimoto I, Kazama K, et al.
Anticancer Res
. 2025 Mar;
45(3):1251-1260.
PMID: 40037866
Background/aim: Malnutrition is a reported prognostic factor in patients with cancer. The controlling nutritional status (CONUT) score, an index calculated from routine laboratory tests, is correlated with the prognosis of...
2.
Yamamoto S, Aoyama T, Maezawa Y, Hashimoto I, Esashi R, Kazama K, et al.
In Vivo
. 2025 Feb;
39(2):885-893.
PMID: 40010995
Background/aim: Esophageal cancer (EC) is a malignant tumor with poor prognosis. Prognostic factors that may be used in the treatment and management of EC are important. The purpose of this...
3.
Asamori T, Katoh H, Takata M, Komura D, Kakiuchi M, Hashimoto I, et al.
J Allergy Clin Immunol
. 2025 Feb;
PMID: 39984131
Background: The pathogenesis of chronic rhinosinusitis with nasal polyps (CRSwNP) remains a subject of discussion. Although both microbial infection and autoimmunity have been proposed as potential contributors to CRSwNP pathobiology,...
4.
Mano Y, Igarashi Y, Komori K, Hashimoto I, Watanabe H, Takahashi K, et al.
Front Immunol
. 2025 Feb;
16:1521278.
PMID: 39949777
The omentum is a common site of peritoneal metastasis in various cancers, including gastric cancer. It contains immune cell aggregates known as milky spots, which provide a microenvironment for peritoneal...
5.
Yamamoto S, Aoyama T, Maezawa Y, Hashimoto I, Esashi R, Kazama K, et al.
Cancer Diagn Progn
. 2025 Jan;
5(1):115-121.
PMID: 39758243
Background/aim: The aim of the present study was to evaluate the clinical impact of the Global Immune-Nutrition-Information Index (GINI) in patients with esophageal cancer (EC) who received curative treatment and...
6.
Aoyama T, Hashimoto I, Maezawa Y, Esashi R, Yamamoto S, Shimada K, et al.
Anticancer Res
. 2024 Dec;
44(12):5551-5557.
PMID: 39626948
Background/aim: This study evaluated the clinical impact of anemia during the perioperative period on both short- and long-term oncological outcomes in resectable gastric cancer (GC) patients who received curative treatment....
7.
Kawahara S, Aoyama T, Murakawa M, Kanemoto R, Takahashi D, Kamioka Y, et al.
BMC Cancer
. 2024 Nov;
24(1):1469.
PMID: 39609741
Purpose: Reports on the association of perioperative nutritional and inflammatory status with the clinical course of adjuvant chemotherapy did not include neoadjuvant chemotherapy. We aimed to clarify the mechanism by...
8.
Yoshizawa S, Kazama K, Otani K, Hashimoto I, Kato A, Maezawa Y, et al.
Gan To Kagaku Ryoho
. 2024 Nov;
51(10):1080-1082.
PMID: 39572003
A 58-year-old man was treated with radical excision for rectal cancer. Pathological findings were pT3N1M0, Stage ⅢB, RAS: mutant, BRAF: mutant, MSS. The patient was followed up without adjuvant chemotherapy....
9.
Hashimoto I, Komori K, Onuma S, Watanabe H, Suematsu H, Nagasawa S, et al.
World J Surg
. 2024 Nov;
49(2):472-482.
PMID: 39542839
Background: The postoperative impact of short-term changes in skeletal muscle loss (SML) and adipose tissue loss (ATL) on treatment outcomes is unclear in patients with gastric cancer (GC). We investigate...
10.
Aoyama T, Maezawa Y, Hashimoto I, Esashi R, Yamamoto S, Kazama K, et al.
In Vivo
. 2024 Oct;
38(6):2928-2934.
PMID: 39477415
Background/aim: We hypothesized that the inflammatory burden index (IBI) is a promising biomarker for esophageal cancer (EC) treatment and management. To confirm our hypothesis, we evaluated the prognostic impact of...